New stock news | Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) filed with the Hong Kong Stock Exchange.

According to the disclosure by the Hong Kong Stock Exchange on April 30, 2026, Anhui Huaheng Biotechnology Co., Ltd. (referred to as Anhui Huaheng Biotechnology Co., Ltd. (688639.SH)) submitted its listing application to the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor. The prospectus shows that Anhui Huaheng Biotechnology Co., Ltd. is the world's first enterprise to achieve industrialization of series of amino acids (including L-proline and L-valine) through anaerobic fermentation. Based on the revenue in 2024, the company's market share for L-proline and L-valine respectively ranked first globally.